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บทคดัยอ่  
วตัถปุระสงค:์ เพื่อศกึษาผลของสมุนไพรหรอือาหารเสรมิต่อค่าไอเอน็อาร ์(INR) 
ในผูป้ว่ยทีใ่ชย้าวารฟ์ารนิ วิธีการศึกษา: การศกึษาแบบยอ้นหลงั โดยใชข้อ้มลูใน
เวชระเบียนและแบบบันทึกข้อมูลผู้ป่วยที่ใช้ยาวาร์ฟาริน ณ คลินิกวาร์ฟาริน 
โรงพยาบาลพระมงกุฎเกลา้ ตัง้แต่วนัที ่1 มกราคม 2556 ถงึ 31 ธนัวาคม 2557 
โดยคดัขอ้มูลค่า INR ก่อนและหลงัการใช้ผลติภณัฑ์สมุนไพรหรอือาการเสรมิ 
ขอ้มลูการใชผ้ลติภณัฑด์า้นขนาดความแรง ปรมิาณและความถี ่และระยะเวลาทีใ่ช ้
พจิารณาแต่ละการใชผ้ลติภณัฑเ์ป็นแต่ละรายงาน ผลการศึกษา: พบผูป้่วย 101 
รายที่ใช้วาร์ฟารนิ ม ี30 รายที่ใช้ผลิตภณัฑ์ โดยมรีายงานเหตุการณ์การใช้ 35 
ครัง้ โดยพบว่าในรายงาน 35 ครัง้ ม ีINR หลงัการใช้อยู่นอกเป้าหมายถงึรอ้ยละ 
94.3 ผลติภณัฑท์ีใ่ชม้ากทีส่ดุ คอื น้ํามนัราํขา้ว (รอ้ยละ 25.7) ขมิน้ชนั (รอ้ยละ 
11.4)  น้ําทบัทมิและชาเขยีว (รอ้ยละ 8.6 เท่ากนั) ตามลําดบั โดยผลติภณัฑท์ีท่าํ
ให ้INR เพิม่ขึน้ไดแ้ก่ น้ํามนัราํขา้ว น้ําทบัทมิ และมะรุม สว่นทีท่าํใหล้ดลง ไดแ้ก่ 
ชาเขยีวและวติามนิซ ีสรปุ: การใชผ้ลติภณัฑส์มุนไพรและอาหารเสรมิทําใหค้่า 
INR เปลี่ยนแปลงได้ ในผู้ป่วยที่ใช้ยาวาร์ฟารนิควรระมดัระวงัการเกิดภาวะ
เลอืดออกผดิปกตหิรอืภาวะลิม่เลือดอุดตนั เพื่อป้องกนัการเกดิผลขา้งเคยีงจาก
ภาวะเลอืดออกผดิปกตหิรอืภาวะลิม่เลอืดอุดตนั  
คาํสาํคญั: วารฟ์ารนิ, ไอเอน็อาร,์ สมนุไพร, อาหารเสรมิ  
   
Abstract 
Objective: To evaluate the effects of herb and dietary supplement products 
on the INR in patients using warfarin. Methods: In this retrospective 
observational study, data from medical records and warfarin clinic form of 
the patients visiting warfarin clinic of Phramongkutklao Hospital, Bangkok, 
Thailand, during Jan. 1, 2013, to Dec. 31, 2014, were abstracted. Data 
regarding the product strength, dosing regimen and duration of use were 
collected. Each episode of the product use was considered an individual 
report. Methods: Of all 101 patients, 30 patients took the products with 35 
individual reports of product use. Of the 35 reports, 94.3% had INR out of 
the target goal. The most used products were rice bran oil (25.7%), 
followed by Curcuma longa (11.4%), pomegranate juice and Camellia 
sinensis (8.6% each). Products that increased INR included rice bran oil, 
pomegranate juice and Moringa oleifera; while those reducing INR were 
Camellia sinensis and vitamin C. Conclusion: The use of herbs and 
dietary supplement products in patients with warfarin use could cause INR 
change which could lead to abnormal bleeding or thrombosis.  
Keywords: warfarin, INR, herbs, dietary supplements 
Introduction
Warfarin therapy is used for prevention of systemic 
thromboembolism in atrial fibrillation, heart valve 
replacement, recurrent ischemic stroke, venous thrombo-
embolism and other causes of cardioembolism.1 The 
International Normalized Ratio (INR) is the most common 
parameter used to monitor warfarin therapy. Warfarin use is 
complicated by the difficulty of achieving goals of INR and 
the maintenance of anticoagulation effects. The goals of INR 
were between 2.0 - 3.0 in patients with atrial fibrillation and 
2.5 - 3.5 in patients with mechanical valve replacement at 
mitral position.2 Warfarin is affected by various factors 
including age, body weight, diet, alcohol intake and drug 
interaction.3 Various mechanisms of warfarin interaction with 
other medications are well known. Absorption of warfarin is 
inhibited by some medications such as cholestyramine or 
sucralfate.4,5 Furthermore, warfarin effect may be decreased 
by high protein diet.6,7 Warfarin undergoes approximately 
60% oxidative metabolism, primarily by 4 cytochrome P450 
(CYP450) isoforms, CYP2C9, CYP1A2, CYP3A4, and to a 
lesser extent, CYP2C19. Warfarin is inhibited by medications 
that induced CYP450 such as rifampicin (CYP3A4), 
phenytoin (CYP2C9) and carbamazepine (CYP2C9). In 
addition, warfarin also interacts with other medications that 
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enhance anticoagulation effect, e.g., metronidazole, amio-
darone, and ketoconazole.1  
Warfarin is highly susceptible to interactions with herb 
and dietary supplement through the effect of enzyme 
induction or inhibition. In addition, herbs and dietary 
supplements may also influence the pharmacodynamics of 
warfarin by inhibiting the synthesis or increasing the 
clearance of vitamin K-dependent coagulation factors, or 
interfering with other pathways of hemostasis.5 Dietary 
supplement such as fish oil enhanced additional 
anticoagulation of warfarin by the inhibition of CYP2C9 and 
CYP3A4.8 Garlic may affect warfarin by inhibiting platelet 
aggregation that increases the risk of bleeding.9 Moreover, 
there are previous studies about herbs that increase warfarin 
effect, including dong quai (Angelica sinensis)10, danshen 
(Salvia miltiorrhiza)11, mango (Mangifera indica)12 and herbs 
that decrease warfarin effect including Korean ginseng 
(Panax ginseng)13 and green tea (Camellia sinensis).14 The 
use of herbs or dietary supplements in patients using 
warfarin are common. Smith et al. reported that 92.2% of 
patients who admitted taking herbal medicines while 
receiving warfarin had not mentioned this use to a 
conventional healthcare provider.15 In Thailand, using herbs 
or dietary supplements is supposed to be more common. 
Furthermore, clinical significant between warfarin and herbs 
or dietary supplement interactions can occur. Health care 
personnel should be educated about the potential risks of 
bleeding or thromboembolism associated with drug 
interaction. The aim of the present study was to evaluate the 
effect of herbal medicines and dietary supplements on the 
INR in patients taking warfarin at the warfarin clinic of 
Phramongkutklao hospital.  
  
Materials and Methods 
This retrospective observational study included data of all 
patients taking warfarin at the warfarin clinic, 
Phramongkutklao hospital, Bangkok, Thailand. Patients’ visit 
data between January 1, 2013 and December 31, 2014 were 
collected. Ethic approval for the study was obtained from the 
Ethic Committee of Phramongkutklao College of Medicine, 
Thailand (IRB/RTA 507/2558, approval date April 9, 2015).  
On a given clinic visit date, the patient’s information was 
abstracted from the medical record, and the patient was 
interviewed using the warfarin clinic data collection form. The 
data collection form in this study was the one used in daily 
practice in Phramongkutklao hospital. The form had been 
developed and modified continuously in the past 13 years of 
its use at the warfarin clinic of Siriraj Hospital, a leading 
medical school hospital. The form was divided into 4 parts 
including 1) characteristics of the patient (such as age, 
gender, co-morbidities leading to warfarin use and other co-
morbidities, history of smoking, alcoholic drinking), 2) history 
of herb or dietary supplement use, 3) the baseline INR value 
before the use of herb/dietary supplement and 4) a set of 5 
questions inquiring herb/dietary use. The 5 questions asked 
1) whether the patient have used or have been using herbs 
or dietary supplement products, 2) if so, what is the 
indication the patient have been using the product for, 3) 
how long the patient have you been using the product, 4) 
how often the patient have been using the product, and 5) 
how many tablets/capsules of the product the patient have 
been taking. With these 5 questions, each herb or dietary 
supplement was identified for type, dose or amount, and 
duration of use. If the patient could not remember trade 
name or type of herb/dietary supplements, the pharmacist 
helped the patient identify the product by using sample 
pictures, either with printed pictures or pictures searched by 
a smart-phone. The process of data collection and product 
identification was conducted by two pharmacists (first and 
third authors).  
Among patients with herb/dietary supplement product 
use, their INR values before and after the use were 
identified. The INR value on that clinic visit was considered 
the post-use value. We further traced back to the clinic visit 
date before the use of such product use with the firstly 
available INR value. This INR value was considered the pre-
use value, or baseline value. The target INR range of each 
patient was identified. For a given patient, more than one 
episode of herb/dietary supplement use with related INR 
values was allowed. Each episode was considered 
independent report. All information gathered was recorded in 
the same data collection form.  
 
Data analysis  
Descriptive statistics, including frequency with 
percentage, and mean with standard deviation were used as 
applicable, to report the patient demographic and clinical 
data, as well as the INR values, i.e., pre- and post-product 
use INR, and target INR range. For each report of the 
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product use, the change of INR value was identified based 
on the pre- and post-product use. The status of the post-use 
INR value, i.e., either within or out-of INR target range, was 
also identified. Frequency and percentage of the INR status 
of all reports were presented. Unit of analysis was based on 
both individual patients and individual product use reports.  
 
 
Results  
A total of 101 patients in warfarin clinic at Phramong-
kutklao hospital were included in the present study. About 
30% of the patients (n = 30) used herbs or dietary 
supplement products. Patient characteristics are shown in 
table 1. The two genders were in equal proportions (51.5% 
female) with a mean age of 56.9  13.7 years old. Most 
patients had a written history of denying smoking and 
alcoholic drinking. The most frequently found indications for 
warfarin use were mitral valve replacement (63.2%) followed 
by atrial fibrillation (35.6%), and aortic valve replacement 
(24.8%). Other co-morbidities were hypertension (24.8%) 
and dyslipidemia (13.9%).  
 
  Table 1  Characteristics of 101 warfarin-treated patients in 
warfarin clinic.   
Parameters 
Number (%) 
among all 
patients 
(N = 101) 
Number (%) among 
patients using 
herbs/dietary supplements 
(N = 30) 
Gender   
Male 49 (48.5) 11 (36.7) 
Female 52 (51.5) 19 (63.3) 
Age, year (mean ± SD)  56.9 ± 13.7 58.8 ± 10.6 
Herbs /dietary supplement use 30 (29.7) 30 (100.0) 
Smoking  
Yes 
No 
Not reported 
6 (5.9) 
87 (86.1) 
8 (7.9) 
1 (3.3) 
27 (90.0) 
2 (6.7) 
Alcohol drinking  
Yes 
No 
Not reported 
7 (6.9) 
85 (84.2) 
9 (8.9) 
1 (3.3) 
26 (86.7) 
3 (10.0) 
Co-morbidities*  
Co-morbidities as warfarin  indication  
Mitral valve replacement  
Atrial fibrillation 
Aortic valve replacement  
64 (63.4) 
36 (35.6) 
25 (24.8) 
17 (56.7) 
15 (50.0) 
6 (20.0) 
Other co-morbidities 
Hypertension 
Dyslipidemia 
Diabetes mellitus 
Chronic kidney disease  
Heart failure 
25 (24.8) 
14 (13.9) 
10 (9.9) 
5 (4.9) 
4 (3.9) 
4 (13.3) 
4 (13.3) 
1 (3.3) 
1 (3.3) 
0 
 * Each patient had 1 or more co-morbidities  
Of the 101 patients, 30 patients reported the product 
use. All 30 patients had INR value at the visit date, i.e., post-
use INR value. Pre-use INR values, i.e., baseline value, for 
all 30 patients were available. Characteristics of 30 patients 
using herb and dietary supplements concomitantly with 
warfarin are shown in table 1 while their 35 reports of INR 
changes and corresponding herb/dietary supplement use, 
classified by INR status are shown in table 2.  
Among 35 reports of INR change with herb/dietary 
supplement product use (table 2), numbers of reports of 
patients with INR target ranges of 2.5 – 3.5 and 2.0 - 3.0 
were comparable, 18 and 17 reports, respectively. Of the 18 
reports with an INR target range of 2.5 – 3.5, all post-use 
INR values were out of target, where the majority had INR 
values of 1.5 to 2.5 (8 of 35 reports, or 22.9%) followed by 
INR  1.5 (14.3%), and INR of 3.5 to 4.9 (11.4%). Only 1 
report (2.9%) was with a post-use INR of  5.0.  
Among the 17 reports with INR target range of 2.0 – 3.0, 
5.7% of the post-use INR values (2 of 35 reports) were 
within target range. The majority of the reports had post-use 
INR values of 1.5 to 2 (7 of 35 reports, or 20.0%), followed 
by INR values of  1.5 (11.4%) and of 3 to 4.9 (11.4%). Only 
1 report (2.9%) was with a post-use INR of  5.0.  
 
  Table 2   Number of reports on INR classified by INR 
target range after the use herb/dietary supplement (30 patients; 
35 reports*).  
Parameters 
N (%) of reports by INR target range 
Out of target 
range (n = 35) 
Within target 
range (n = 35) 
All patients using herb/dietary 
supplement  
33 (94.3) 2 (5.7) 
Target INR of 2.5 - 3.5  
post-use INR ≤ 1.5   
post-use 1.5 < INR < 2.5  
post-use 3.5 < INR ≤ 4.9  
post-use INR ≥ 5  
18 (51.4) 
5 (14.3) 
8 (22.9) 
4 (11.4) 
1 (2.9) 
- 
- 
- 
- 
- 
Target INR of 2 - 3  
post-use INR ≤ 1.5  
post-use 1.5 < INR < 2  
post-use 3 < INR ≤ 4.9  
post-use INR ≥ 5  
15 (42.9) 
4 (11.4) 
7 (20.0) 
4 (11.4) 
1 (2.9) 
2 (5.7) 
- 
- 
- 
- 
* A given patient could have more than 1 report.   
 
Among the 30 patients, the most frequently used 
herb/dietary supplement was rice bran oil which was used by 
25.7% of patients, followed by turmeric (Curcuma longa) 
(11.4%), green tea (Camellia sinensis) and  pomegranate 
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juice (8.6% each), and chlorophyll juice and gotu kola 
(Centella asiatica) (5.7% each). Each of the remaining 
herbs/dietary supplements was used in one patient.  
 
 
 Table 3  Types of herbs and dietary supplements (N = 30).  
Herbs and dietary supplement Frequency (%)  
Rice bran oil   9 (25.7) 
Turmeric (Curcuma longa)  4 (11.4) 
Pomegranate juice  3 (8.6) 
Green tea (Camellia sinensis)   3 (8.6) 
Chlorophyll juice  2 (5.7) 
Gotu kola (Centella asiatica)  2 (5.7) 
Moringa (Moringa oleifera Lam.) 1 (2.9) 
Ginkgo (Ginkgo Biloba) 1 (2.9) 
Andawali (Tinospora crispa) 1 (2.9) 
Lingzhi (Ganoderma lucidum) 1 (2.9) 
Ginger (Zingiber officinale) 1 (2.9) 
Black pepper (Piper nigrum) 1 (2.9) 
Andrographis (Andrographis paniculata) 1 (2.9) 
Lemon grass (Cymbopogon citratus) 1 (2.9) 
Gaertner (Alpinia nigra) 1 (2.9) 
Black thai ginger (Kaempferia parviflor) 1 (2.9) 
Aloe vera (Aloe barbadenisis) 1 (2.9) 
Vitamin C 1 (2.9) 
  
 
In table 4, changes of INR in individual reports are 
shown. Of the 9 reports with rice bran oil use, somewhat 
comparable numbers of reports with an increase and 
decrease of INR were found (5 and 4 reports, respectively). 
Among the 4 reports with turmeric use, a decrease of INR 
was found in the majority of reports (3 or 4). The use of 
pomegranate juice was associated with a consistent increase 
of INR values found in all 3 reports. Chlorophyll juice was 
associated with a decrease of INR values, found in all 2 
reports.  
All two reports of gotu kola use contained increased INR 
values; while moringa use was associated with an increased 
INR as high as 6.4. A report of ginkgo use contained an INR 
decrease. Three reports of green tea were all associated 
with the decrease of INR values. Andawali use was 
associated with an INR increase as seen in one report. 
Other product uses associated in an increase of INR 
included ginger, andrographis, and aloe vera; while the ones 
with an INR decrease included lingzhi, black pepper, lemon 
grass, gaertner, black Thai ginger and vitamin C, with one 
report each.  
 
 Table 4  Effects of herbs and dietary supplements on INR, 
classified by number of report (30 patients; 35 reports).  
Report 
No.  
(n = 35) 
Patient  
No.  
(n = 30) 
Target  
INR 
Pre-use 
INR 
Herbs/dietary supplements 
Post-
use INR 
INR 
change* 
1 1 2.5 - 3.5 3.2 Rice bran oil  3.6 ↑ 
2 2 2.5 - 3.5 1.6 Rice bran oil  5.0 ↑ 
3 3 2.0 - 3.0 2.4 Rice bran oil  4.4 ↑ 
4 4 2.0 - 3.0 1.5 Rice bran oil  2.6 ↑ 
5 5 2.0 - 3.0 1.2 Rice bran oil 1.7 ↑ 
6 6 2.5 - 3.5 2.1 Rice bran oil  1.2  
7 7 2.5 - 3.5 3.7 Rice bran oil  2.3  
8 8 2.0 - 3.0 1.9 Rice bran oil  1.5  
9 9 2.0 - 3.0 2.1 Rice bran oil  1.5  
10 10 2.5 - 3.5 5.9 Turmeric (Curcuma longa) 3.8  
11 11 2.0 - 3.0 2.8 Turmeric (Curcuma longa) 1.7  
12 12 2.0 - 3.0 1.9 Turmeric (Curcuma longa) 1.7  
13 13 2.0 - 3.0 1.5 Turmeric (Curcuma longa) 1.8 ↑ 
14 14 2.0 - 3.0 2.1 Pomegranate juice 3.2 ↑ 
15 5 2.0 - 3.0 2.5 Pomegranate juice 3.8 ↑ 
16 15 2.5 - 3.5 1.6 Pomegranate juice 1.9 ↑ 
17 16 2.5 - 3.5 1.8 Chlorophyll juice 1.3  
18 17 2.5 - 3.5 1.7 Chlorophyll juice 1.2  
19 18 2.5 - 3.5 2.9 Gotu kola (Centella asiatica) 4.1 ↑ 
20 19 2.5 - 3.5 1.7 Gotu kola (Centella asiatica) 2.2 ↑ 
21 20 2.0 - 3.0 1.9 Moringa (Moringa oleifera) 6.4 ↑ 
22 21 2.0 - 3.0 1.7 Ginkgo (Ginkgo biloba) 1.6  
23 22 2.5 - 3.5 2.1 Green tea (Camellia sinensis) 1.7  
24 23 2.5 - 3.5 3.6 Green tea (Camellia sinensis) 1.6  
25 24 2.5 - 3.5 2.3 Green tea (Camellia sinensis) 1.5  
26 25 2.5 - 3.5 1.8 Andawali (Tinospora crispa) 4.2 ↑ 
27 26 2.0 - 3.0 2.3 Lingzhi (Ganoderma lucidum) 1.4  
28 27 2.0 - 3.0 1.5 Ginger (Zingiber officinale) 1.7 ↑ 
29 28 2.0 - 3.0 1.8 Black pepper (Piper nigrum) 1.5  
30 12 2.0 - 3.0 1.5 Andrographis (Andrographis paniculata) 1.8 ↑ 
31 29 2.5 - 3.5 3.3 Lemon grass (Cymbopogon citrates) 1.8  
32 29 2.5 - 3.5 1.8 Gaertner (Alpinia nigra) 1.6  
33 10 2.5 - 3.5 2.1 Black Thai ginger (Kaempferia 
parviflora)  
1.6  
34 14 2.0 - 3.0 1.6 Aloe vera (Aloe barbadenisis) 2.0 ↑ 
35 30 2.5 - 3.5 3.9 Vitamin C (Ascorbic acid) 1.5  
 * ↑ = increase;  = decrease   
 
Discussions and Conclusions  
The response to warfarin therapy is associated with 
many factors. One of them was the use of herbs and dietary 
supplements. The interactions between herb/dietary 
supplement and warfarin were attributable to pharmaco-
kinetic and pharmacodynamic interactions. The present 
study showed effect of herbs and dietary supplements on the 
INR change. The detail of each of the herbs and dietary 
supplements on potential pharmacodynamic and pharmaco-
kinetic interactions are discussed as the following.  
   
Rice bran oil  
Rice bran oil and its main components including 
unsaturated fatty acids, triterpene alcohols, phytosterols, 
tocotrienols, alpha-tocopherol, and gamma-oryzanol had 
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demonstrated an ability to reduce plasma cholesterol and 
triglyceride; it is thus has been used for dyslipidemia.16,17 
Gamma-oryzanol, an antioxidant, is associated with platelet 
aggregation reduction and inhibiting effects on CYP1A2, 
CYP2C9 and CYP3A4.18 INR in the patient using warfarin 
with rice bran oil should be increased, and lead to a potential 
for an increased risk of bleeding. However, effects of rice 
bran oil on warfarin were limited to case reports. In the 
present study, we found 9 reports of patients who used rice 
bran oil, 5 reports with increased INR and 4 reports 
decreased INR. The results of 4 reports with a conflicting 
decrease of INR could result from the reduction of the 
warfarin dose on the last visit (2 reports). However, no 
known causes could be expected in the other 2 reports. With 
its retrospective nature, specific causes of these decreases 
could not be verified in this study.  
 
Pomegranate juice 
The present study found 3 reports with the use of 
pomegranate juice. Pomegranate was associated with 
increased INR in all reports. There have been a limited 
number of cases on the effect of pomegranate on INR. A 
previous case report described a 64-year-old woman who 
used warfarin with a stable dosage of warfarin and had an 
INR within goal.19 Her INR rose up after the patient 
consumed pomegranate juice 2 - 3 times per week. Once 
stopping drinking the juice, her INRs went down within the 
therapeutic range.19 Jarvis et al. reported that a 37-year-old 
woman consumed pomegranate juice about 3 liters. In a 
week before hospital admission, her INR value was elevated 
with hematoma.20 In addition, Usia et al. reported the effect 
of Punica granatum inhibitory activity against CYP2D6 and 
CYP3A418 which further confirmed that warfarin is 
metabolized by CYP3A4. Furthermore, pomegranate juice 
could inhibit platelet aggregation, the first step of 
coagulation, resulting in an increasing prolonged bleeding 
time and a higher risk of bleeding.21  
 
Turmeric (Curcuma longa)  
Turmeric is an antioxidant, anti-bacterial and pain 
reliever. Previous study in animal study has shown an effect 
of a decreased platelet aggregation and increased 
bleeding.22 Moreover, turmeric could also inhibit CYP3A4.23 
In our present study, 3 of 4 reports with turmeric use were 
associated with a decreased INR. Of the 3 reports, a cause 
of the decreased INR in 1 report was the decreased dosing 
of warfarin. Causes of the interaction leading to INR changes 
in the other cases could not be identified.  
 
Gotu kola (Centella asiatica) 
Gotu kola (Centella asiatica) has been used for many 
purposes such as healing wounds, improving mental clarity, 
and curing psoriasis.24 In two reports in this study, the use of 
C. asiatica was associated with elevated INR level which 
was in accordance with pharmacokinetic interaction basis. In 
vitro studies, it was found that C. asiatica extracts inhibited 
CYP2C9, CYP2D6 and CYP3A4 activities.25 This could 
enhance effect of warfarin. However, previous case reports 
on the interaction between C. asiatica and warfarin have not 
been reported.  
 
Moringa (Moringa oleifera) 
M. oleifera is a tropical tree often used as an herbal 
medicine. Monera et al. found that the extracts of M. oleifera 
on the CYP3A4 possess significant CYP3A4 inhibitory 
effects.26 There has been no case report indicating 
interaction between warfarin and M. oleifera. In the present 
study, one patient taking two capsules per day of M. oleifera 
extract with no known duration of use. The patient’s INR was 
found increasing without abnormal bleeding. The information 
found in the medical records indicated the patient’s good 
compliance and denied use of other medications. In addition, 
the patient did not have other conditions, such as heart 
failure and hyperthyroidism, which may potentially influence 
the increase of warfarin action.  
 
Ginkgo (Ginkgo biloba)  
Ginkgo biloba has been well known to increase 
bleeding.27 A 78-year-old woman took warfarin with ginkgo 
and developed a subsequent intracerebral hemorrhage.28 In 
addition, a study revealed that ginkgo preparation had 
demonstrated an antiplatelet activity in vitro and may 
potentially increase bleeding time.29 Mohutsky et al. reported 
G. biloba extract could inhibit CYP2C9 in an in vitro study 
but no interaction between G. biloba with probe for CYP2C9 
was found.30 In contrast, our study showed a decreased INR 
in patients taking gingko with warfarin. In the patient medical 
record, we found no specific causes since the patient had a 
good compliance and used no other medications potentially 
interfere with warfarin therapy. Other information, such as 
social history and vegetable consumption, was not recorded.  
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Green tea (Camellia sinensis) 
In our present study, all 3 reports had an INR decrease 
from baseline after the use of green tea. The antagonistic 
activity of green tea toward warfarin is associated with its 
high content of vitamin K, about 1,428 microgram per 100 
grams.31 In a previous case report, a 44-year-old man 
received warfarin for thromboembolic prophylaxis for his 
mechanical valve replacement (St. Jude) in the aortic 
position. His INR decreased from 3.79 to 1.14 after taking 
one-half to one gallon per day of green tea for one week. 
After discontinuing green tea, the INR increased..32 In our 
study, a decrease of INR could also be attributable to the 
patient’s forgetting taking 2 doses of warfarin about a month 
before the INR measurement.  
  
Andawali (Tinospora crispa)  
In our study, a patient used T. crispa extract for 5 
milliliters every day for a month. Her INR level increased 
from 1.48 to 4.28. As suggested by the medical record, the 
INR increase could be due to the increased doses of 
warfarin and an unusual vegetable consumption. Previous 
cases on interaction between T. crispa and warfarin have not 
been reported. Based on pharmacokinetic basis, Usia et al. 
reported that more than 70% of the inhibitory effect of T. 
crispa on metabolism of warfarin was mediated by CYP3A4 
in an in vitro study.18  
   
Lingzhi (Ganoderma lucidum) 
G. lucidum is a popular Asian herb. The health benefits 
of lingzhi include control of blood glucose level, modulation 
of the immune system, hepatoprotection, bacteriostasis, and 
more.33 A previous report showed the additional effect of 
warfarin with the use of lingzhi through the increased 
inhibition of platelet aggregation.34 This could lead to 
bleeding but no cases of lingzhi and anticoagulants have 
been reported. Thus such interaction could not be 
established up to date.  
This present study showed that a single patient taking 
lingzhi had a decreased INR which was in contrast with the 
existing knowledge. We could not verify specific cause of 
this INR decrease because related information was not 
adequately documented in the medical record. Furthermore, 
the patient, as suggested by the medical record, had a good 
compliance to warfarin therapy and did not use other 
medications which could influence pharmacodynamic 
interaction with warfarin.  
 
Ginger (Zingiber officinale) 
This study showed the increase of INR in a patient 
consuming ginger concomitantly with warfarin. Previously, a 
case report demonstrated an interaction of ginger and 
phenprocoumon resulting in an elevated INR with epistaxis.35 
Furthermore, ginger was reported to have antiplatelet effect 
by inhibiting thromboxane synthetase, as a result, platelet 
aggregation was decreased.5,36  
 
Black pepper (Piper nigrum)  
Black pepper is widely used in traditional medicines. It 
shows over 70% inhibitory activity on the metabolism 
mediated by CYP3A4.18 Thus black pepper could potentially 
increase warfarin effect; although not even one incident of 
interaction between black pepper and warfarin has been 
reported. Our present study showed that a patient using 
warfarin with black pepper had a decreased INR level. The 
cause of INR decrease was verified as non-compliance.  
 
Kariyat (Andrographis paniculata)  
A. paniculata has been widely used for the prevention 
and treatment of common cold especially in Asia and 
Scandinavia. A. paniculata may help prevent some 
cardiovascular disorders, because its active compound 
(andrographolide) possesses an inhibitory effect on platelet 
aggregation.37 Moreover, A. paniculata showed an inhibitory 
activity on the warfarin metabolism mediated by CYP3A4.18 It 
thus should be used with caution by patients taking warfarin. 
Our finding was consistent with such pharmacokinetic 
interaction basis. A patient had taken kariyat 1 capsule per 
day about 2 - 3 weeks before the INR increased from 2.8 to 
3.2. However, the information documented in the medical 
record was inadequate to eliminate other possible causes of 
the increase of INR.  
 
Lemon grass (Cymbopogon citratus)  
In an animal study, C. citratus was hypothesized to have 
antiplatelet activity.38 Thus, patients who consume C. citratus 
with warfarin may have an increased risk of bleeding. Our 
finding pointed to the opposite where a patient using warfarin 
with C. citratus had a reduced INR. However, with a 
retrospective nature of this study, essential information could 
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not be retrieved and specific causes of this incident could 
not be verified.  
 
Black Thai ginger (Kaempferia parviflora)  
Cases on interaction between K. parviflora and warfarin 
have not been reported. An in vitro study showed K. 
parviflora extract had an inhibitory effect on CYP2D6 and 
CYP1A2 activity.39 Therefore, patients who consume K. 
parviflora with warfarin may increase the risk of bleeding. 
With a report of such use in this study, the patient used 
warfarin with K. parviflora had a decreased INR. This effect 
could be more due to a decreasing dose of warfarin than the 
use of K. parviflora.   
 
Vitamin C (Ascorbic acid) 
An interaction between warfarin and vitamin C has been 
described in case reports.40 In a study, 5 patients who 
received warfarin therapy for myocardial infarction were also 
given 1 gram of ascorbic acid daily for 14 days.41 The 
researcher recorded data before and after starting vitamin C. 
The result showed that while the INR values were reduced, 
the dose of warfarin was kept at the same level for each 
patient throughout the six weeks of follow-up. The 
mechanism of this potential interaction is not clear. A 
possible explanation for this interaction is the role of vitamin 
C as a potential chelating agent to decrease warfarin 
absorption.41 In our present study, a 56-year-old Thai man 
patient took warfarin with ascorbic acid (1.5 gram per day), 
approximately 30 days before the INR measurement. His 
INR was reduced. We did not find other causes of the 
decreased INR such as non-compliance or unusual 
vegetable consumption.  
 
Aloe vera (Aloe barbadenisi) and gaertner (Alpinia 
nigra)  
There is a lack of data about effect on warfarin included 
clinical studies or case report.  
 
Conclusion  
The present study showed some conflicting results with 
the previous studies. The results of the present study could 
guide the prediction of the warfarin effect when used 
concomitantly with herbs or dietary supplements, especially 
those with the lack of evidence about the effects on warfarin. 
It is also implying that it is possible for pharmacists to 
prevent the interactions between warfarin and herb/dietary 
supplement by monitoring the use of all herbs and dietary 
supplements with documented interactions with warfarin, and 
more importantly those with a lack of evidence. Studies on 
the evaluation of the effect of herbs or dietary supplements 
on warfarin are needed in the near future.  
Future researches are needed in part because of the 
limitations of our study. This study was retrospective in 
design which could be the source missing data and further to 
a recall bias. With imperfect data available in the patient 
medical records, we encourage future research with 
prospective design. This could help assure the factors 
potentially affect the change of INR. In addition, more 
reliable method or algorithm to help evaluate the possibility 
of the interaction between herb/dietary supplement should be 
used so that the cause-effect relationship could be 
established with a greater confidence.  
In summary, the present study had identified the possible 
effects of herbs and dietary supplements on INR, in warfarin 
users, at Phramongkutklao hospital. Patients on warfarin 
were specifically advised to avoid taking herbs or dietary 
supplements or have their INR closely monitored when the 
use of herbs or dietary supplement product is changed, 
either by adding the product to the regimen, increasing or 
decreasing the product dose. Pharmacists should educate 
the warfarin-taking patients about the possibility and 
consequence of such interaction, and inquire the use of any 
herbs or dietary supplements, as well as other alternative 
medicine products.  
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